Vito M. Campese
#151,228
Most Influential Person Now
Vito M. Campese's AcademicInfluence.com Rankings
Vito M. Campesephilosophy Degrees
Philosophy
#8377
World Rank
#11742
Historical Rank
Logic
#5409
World Rank
#6804
Historical Rank
Vito M. Campesebiology Degrees
Biology
#11327
World Rank
#14715
Historical Rank
Physiology
#360
World Rank
#577
Historical Rank
Download Badge
Philosophy Biology
Vito M. Campese's Degrees
- Doctorate Medicine University of California, San Francisco
- PhD Physiology University of California, San Francisco
Why Is Vito M. Campese Influential?
(Suggest an Edit or Addition)Vito M. Campese's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Diurnal variations of blood pressure and microalbuminuria in essential hypertension. (1994) (381)
- Renal afferent denervation prevents hypertension in rats with chronic renal failure. (1995) (360)
- Salt sensitivity in hypertension. Renal and cardiovascular implications. (1994) (358)
- Microalbuminuria predicts cardiovascular events and renal insufficiency in patients with essential hypertension (1998) (356)
- A controlled, prospective study of the effects of atorvastatin on proteinuria and progression of kidney disease. (2003) (344)
- "Zero ischemia" partial nephrectomy: novel laparoscopic and robotic technique. (2011) (312)
- Abnormal relationship between sodium intake and sympathetic nervous system activity in salt-sensitive patients with essential hypertension. (1982) (303)
- Long-term effects of spironolactone on proteinuria and kidney function in patients with chronic kidney disease. (2006) (301)
- Microalbuminuria in salt-sensitive patients. A marker for renal and cardiovascular risk factors. (1994) (252)
- Abnormal Renal Hemodynamics in Black Salt-Sensitive Patients With Hypertension (1991) (204)
- Microalbuminuria in essential hypertension: significance, pathophysiology, and therapeutic implications. (1999) (193)
- Reactive oxygen species stimulate central and peripheral sympathetic nervous system activity. (2004) (180)
- Renal afferent impulses, the posterior hypothalamus, and hypertension in rats with chronic renal failure. (1997) (173)
- Prevalence of microalbuminuria in a large population of patients with mild to moderate essential hypertension. (1992) (166)
- Renal afferent denervation prevents the progression of renal disease in the renal ablation model of chronic renal failure in the rat. (1995) (161)
- Effect of sodium intake on plasma catecholamines in normal subjects. (1979) (156)
- Antagonists of aldosterone and proteinuria in patients with CKD: an uncontrolled pilot study. (2005) (148)
- Mechanisms of autonomic nervous system dysfunction in uremia (1981) (146)
- Oxidative Stress Mediates Angiotensin II–Dependent Stimulation of Sympathetic Nerve Activity (2005) (140)
- International expert consensus statement: Percutaneous transluminal renal denervation for the treatment of resistant hypertension. (2013) (138)
- Hypertension in renal parenchymal disease: why is it so resistant to treatment? (2006) (136)
- Renal injury caused by intrarenal injection of phenol increases afferent and efferent renal sympathetic nerve activity. (2002) (130)
- Increased thickness of the carotid artery in patients with essential hypertension and microalbuminuria. (1995) (125)
- Pleiotropic effects of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors on renal function. (2005) (124)
- Mechanisms of autonomic nervous system dysfunction in uremia. (1982) (122)
- A limited renal injury may cause a permanent form of neurogenic hypertension. (1998) (113)
- Microalbuminuria in essential hypertension. (1997) (113)
- Nitric oxide (NO) modulates the neurogenic control of blood pressure in rats with chronic renal failure (CRF). (1997) (110)
- Salt intake and plasma atrial natriuretic peptide and nitric oxide in hypertension. (1996) (107)
- Losartan Reduces Central and Peripheral Sympathetic Nerve Activity in a Rat Model of Neurogenic Hypertension (2002) (98)
- Oxidative Stress Mediates the Stimulation of Sympathetic Nerve Activity in the Phenol Renal Injury Model of Hypertension (2006) (95)
- Clustering of cardiovascular risk factors in salt-sensitive patients with essential hypertension: role of insulin. (1996) (94)
- Elevated serum insulin levels in patients with essential hypertension and microalbuminuria. (1994) (92)
- Downregulation of Neuronal Nitric Oxide Synthase and Interleukin-1&bgr; Mediates Angiotensin II-Dependent Stimulation of Sympathetic Nerve Activity (2002) (83)
- Evaluation of serum creatinine for estimating glomerular filtration rate in African Americans with hypertensive nephrosclerosis: results from the African-American Study of Kidney Disease and Hypertension (AASK) Pilot Study. (1997) (80)
- Effects of omapatrilat on the renin-angiotensin system in salt-sensitive hypertension. (2002) (80)
- Consensus Development Conference on the Diagnosis and Management of Nephropathy in Patients with Diabetes Mellitus (1994) (78)
- Neurogenic factors and hypertension in renal disease. (2000) (75)
- Microalbuminuria in patients with essential hypertension: effects of several antihypertensive drugs. (1992) (72)
- Altered norepinephrine turnover in the brain of rats with chronic renal failure. (1994) (67)
- Renal and Cardiovascular Implications (2005) (65)
- Enhanced Glucose Tolerance in Spontaneously Hypertensive Rats: Pancreatic β-Cell Hyperfunction With Normal Insulin Sensitivity (1992) (64)
- HMG-CoA reductase inhibitors and the kidney. (2007) (61)
- Omapatrilat Versus Lisinopril: Efficacy and Neurohormonal Profile in Salt-Sensitive Hypertensive Patients (2001) (58)
- Association between hyperlipidemia and microalbuminuria in essential hypertension. (1999) (58)
- Role of sympathetic nerve inhibition and body sodium-volume state in the antihypertensive action of clonidine in essential hypertension. (1980) (57)
- Neurogenic factors in renal hypertension (2002) (57)
- Are 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors renoprotective? (2005) (57)
- Regional expression of NO synthase, NAD(P)H oxidase and superoxide dismutase in the rat brain (2007) (55)
- Neurogenic factors and hypertension in chronic renal failure. (1997) (54)
- Hypokalemic effects of intravenous infusion or nebulization of salbutamol in patients with chronic renal failure: comparative study. (1994) (51)
- The Importance of Understanding the Stages of COVID-19 in Treatment and Trials. (2021) (49)
- Differential distribution of muscle and skin sympathetic nerve activity in patients with end-stage renal disease. (2008) (49)
- Minoxidil: A Review of its Pharmacological Properties and Therapeutic Use (1981) (47)
- Interleukin-1β and neurogenic control of blood pressure in normal rats and rats with chronic renal failure (2000) (46)
- Abnormal norepinephrine uptake and release in brain synaptosomes in chronic renal failure. (1989) (45)
- Plasma catecholamines and autonomic nervous system function in patients with early renal insufficiency and hypertension: effect of clonidine. (1984) (45)
- The kidney and hypertension: over 70 years of research. (2006) (44)
- Effect of phosphate depletion on blood pressure and vascular reactivity to norepinephrine and angiotensin II in the rat. (1985) (44)
- Unilateral breast enlargement secondary to hemodialysis arteriovenous fistula and subclavian vein occlusion. (1993) (44)
- Pregnancy in patients on chronic ambulatory peritoneal dialysis. (1992) (43)
- Microalbuminuria in patients with essential hypertension. Effects of an angiotensin converting enzyme inhibitor and of a calcium channel blocker. (1991) (43)
- Effect of PTH on blood pressure and response to vasoconstrictor agonists. (1985) (43)
- Effect of long-term therapy with captopril on proteinuria and renal function in patients with non-insulin-dependent diabetes and with non-diabetic renal diseases. (1995) (42)
- Long-term effects of enalapril and nicardipine on urinary albumin excretion in patients with chronic renal insufficiency: a 1-year follow-up. (1991) (41)
- Intestinal absorption of calcium and calcium metabolism in patients with essential hypertension and normal renal function. (1991) (40)
- Abnormal sympathetic reactivity to the cold pressor test in overweight humans. (2012) (40)
- Long-term effects of a converting enzyme inhibitor and a calcium channel blocker on urinary albumin excretion in patients with essential hypertension. (1993) (39)
- Serum calcium, parathyroid hormone, and blood pressure. (1986) (37)
- Effect of dietary sodium intake on intracellular calcium in lymphocytes of salt-sensitive hypertensive patients. (1992) (37)
- Acute Declines in Renal Function during Intensive BP Lowering: Implications for Future ESRD Risk. (2017) (37)
- Disparate prognosis of thrombotic microangiopathy in HIV-infected patients with and without AIDS. (1996) (37)
- Clinical characteristics of resistant hypertension: the importance of compliance and the role of diagnostic evaluation in delineating pathogenesis. (2007) (37)
- Evidence that prostacyclin modulates the vascular actions of calcium in man. (1986) (34)
- Sympathetic Renal Innervation and Resistant Hypertension (2011) (34)
- Intensive versus conventional therapy to slow the progression of idiopathic glomerular diseases. (2010) (34)
- Autonomic nervous system dysfunction and impotence in uremia. (1982) (34)
- Renal hemodynamic effects of vasodilation with nifedipine and hydralazine in patients with heart failure. (1984) (33)
- Treatment of Severe Hypertension with Minoxidil: Advantages and Limitations (1979) (33)
- Exercise pressor reflex in humans with end-stage renal disease. (2008) (32)
- Is microalbuminuria a predictor of cardiovascular and renal disease in patients with essential hypertension? (2000) (32)
- Pressor reactivity to norepinephrine and angiotensin in salt-sensitive hypertensive patients. (1993) (31)
- Effect of High-Dose Atorvastatin on Renal Function in Subjects With Stroke or Transient Ischemic Attack in the SPARCL Trial (2014) (31)
- Acute renal failure during intermittent rifampicin therapy. (1973) (31)
- Effect of Chronic Renal Failure on Heart (1986) (29)
- Effects of calcium antagonists on deranged modulation of the renal function curve in salt-sensitive patients with essential hypertension. (1988) (27)
- Calcium, parathyroid hormone, and blood pressure. (1989) (27)
- Minoxidil therapy in refractory hypertension analysis of 155 patients. (1978) (27)
- Responses of proximal tubule sodium transporters to acute injury-induced hypertension. (2003) (27)
- Effects of hypercalcemia and parathyroid hormone on blood pressure in normal and renal-failure rats. (1986) (26)
- Autonomic nervous system dysfunction in uraemia. (1990) (25)
- Chronic renal injury-induced hypertension alters renal NHE3 distribution and abundance. (2003) (24)
- Central and renal hemodynamic effects and hormonal response to diltiazem in severe congestive heart failure. (1987) (22)
- HMG-CoA reductase inhibitors and the kidney (2005) (22)
- Aldosterone in the Pathogenesis of Chronic Kidney Disease and Proteinuria (2010) (22)
- A Multicenter Trial to Evaluate the Use of the CAPD “O” Set (1986) (21)
- Electrophysiological and clinical consequences of hyperkalemia. (2016) (21)
- The kidney and the neurogenic control of blood pressure in renal disease. (1999) (20)
- Losartan reduces sympathetic nerve outflow from the brain of rats with chronic renal failure (2000) (20)
- Regional Expression of NAD(P)H Oxidase and Superoxide Dismutase in the Brain of Rats with Neurogenic Hypertension (2008) (19)
- HMG-CoA reductase inhibitors and renal function. (2007) (18)
- Pathophysiology of resistant hypertension in chronic kidney disease. (2014) (18)
- Con: Mesoamerican nephropathy: is the problem dehydration or rehydration? (2017) (18)
- Parathyroid hormone and the altered vascular response to norepinephrine in uremia. (1985) (18)
- Salt sensitivity in hypertension: implications for the kidney. (1991) (18)
- Tuberculosis of the spine (Pott's disease) in patients with end-stage renal disease. (1994) (18)
- A new model of neurogenic hypertension caused by renal injury: pathophysiology and therapeutic implications (2003) (18)
- High salt intake inhibits nitric oxide synthase expression and aggravates hypertension in rats with chronic renal failure. (2002) (17)
- Relationship between plasma catecholamines, plasma renin activity, aldosterone, and arterial pressure during postural stress in normal subjects. (1980) (17)
- IgA nephropathy in a patient with ulcerative colitis, Graves' disease and positive myeloperoxidase ANCA. (2012) (16)
- Statin use in patients with diabetes and kidney disease: the Japanese experience. (2013) (16)
- Evidence for a role of PTH in the reduced pressor response to norepinephrine in chronic renal failure. (1985) (16)
- Sexual dysfunction in uremia. Endocrine and neurological alterations. (1990) (16)
- Hypertension in High School Students: Genetic and Environmental Factors: The HYGEF Study. (2019) (16)
- The time to offer treatments for COVID-19 (2021) (16)
- Sexual Dysfunction in Uremia (1990) (15)
- Hyperinsulinemia, circadian variation of blood pressure and end-organ damage in hypertension. (1997) (15)
- Autonomic nervous system dysfunction in patients with acute renal failure. (1982) (15)
- Metabolic risk factors and markers of cardiovascular and renal damage in overweight subjects. (2006) (14)
- Increased cardiovascular events in hypertensive patients with insulin resistance: a 13-year follow-up. (2008) (14)
- Silent ischemia is more prevalent among hypertensive patients with microalbuminuria and salt sensitivity (2003) (14)
- Salt-sensitive hypertension: renal and cardiovascular implications. (1999) (13)
- Pharmacokinetics of Atenolol in Patients Treated With Chronic Hemodialysis or Peritoneal Dialysis (1985) (13)
- Adverse drug responses: An increasing threat to the well-being of older patients: Comment on "Development and validation of a score to assess risk of adverse drug reactions among in-hospital patients 65 years or older". (2010) (13)
- ImmunoDip®: An Improved Screening Method for Microalbuminuria (2004) (13)
- Dyslipidemia and progression of kidney disease: role of lipid-lowering drugs (2014) (13)
- Reevaluating the Use of Antihypertensive Medications, a First Step Toward Reducing Polypharmacy in Very Old Patients (2010) (12)
- Neurogenic factors in low renin essential hypertension. (1980) (12)
- The hazards of dual renin-angiotensin blockade in chronic kidney disease. (2009) (11)
- The Mesoamerican nephropathy: a regional epidemic of chronic kidney disease? (2016) (11)
- A vitamin-E-fortified diet reduces oxidative stress, sympathetic nerve activity, and hypertension in the phenol-renal injury model in rats. (2007) (11)
- Sympatho-adrenal system and the kidney in hypertension. (1983) (10)
- Do HMG-CoA reductase inhibitors improve kidney function? The saga continues. (2011) (10)
- Aldosterone and hypertension in African Americans. (2009) (10)
- Left ventricular function and chronic kidney disease: how soon does it start? (2014) (10)
- Interventional hypertension: a new hope or a new hype? The need to redefine resistant hypertension. (2013) (10)
- Why is salt-sensitive hypertension so common in blacks? (1997) (10)
- The kidney in the hypertensive black. (1996) (9)
- Cardiovascular instability during hemodialysis. (1988) (9)
- ANGIOTENSIN RECEPTOR BLOCKER TELMISARTAN IMPROVES INSULIN SENSITIVITY IN PERITONEAL DIALYSIS PATIENTS (2010) (9)
- Effect of chronic renal failure on heart. Role of secondary hyperparathyroidism. (1986) (9)
- Bilateral renal cortical necrosis in two patients with Neisseria meningitidis sepsis. (1991) (9)
- Is hypertension in chronic renal failure neurogenic in nature? (1994) (9)
- Lixivaptan: a novel vasopressin receptor antagonist (2009) (9)
- Effect of renal injury-induced neurogenic hypertension on NO synthase, caveolin-1, AKt, calmodulin and soluble guanylate cyclase expressions in the kidney. (2007) (9)
- A 19-year-old female with fever, acroparesthesia, and progressive deterioration of renal function. (1996) (9)
- The role of hypertension in the progression of renal diseases. (1991) (8)
- Role of aldosterone in the progression of chronic kidney disease and potential use of aldosterone blockade in children (2009) (8)
- Altered norepinephrine turnover in the brown fat of rats with chronic renal failure. (1994) (8)
- Statins and the kidney: friend or foe? (2015) (8)
- Interleukin-1beta and neurogenic control of blood pressure in normal rats and rats with chronic renal failure. (2000) (8)
- HYPERTENSION IN HIGH SCHOOL STUDENTS: GENETIC AND ENVIRONMENTAL FACTORS (HYGEF STUDY) (2018) (8)
- Hypertension, hyperlipidemia and microalbuminuria. (1997) (8)
- Dietary salt intake, blood pressure and the kidney in hypertensive patients with non-insulin dependent diabetes mellitus. (1998) (8)
- Plasma catecholamines and vascular reactivity in uremic and dialysis patients. (1984) (8)
- Calcium, parathyroid hormone, and sympathoadrenal system. (1986) (7)
- Is Lipid Management Effective for All Stages of CKD (2013) (7)
- Hypertension in a renal transplant recipient. (1984) (7)
- Effects of acute and chronic treatment with clonidine. (1983) (7)
- Hemodynamic alterations and urinary albumin excretion in patients with essential hypertension. (1993) (7)
- Renal hemodynamics and pharmacokinetics of bevantolol in patients with impaired renal function. (1986) (6)
- The unresolved epidemic of chronic kidney disease of uncertain origin (CKDu) around the world: A review and new insights. (2020) (6)
- Lixivaptan: a novel vasopressin receptor antagonist. (2009) (6)
- Measurement of Cardiac Output and Blood Volume During Hemodialysis with Fluorescent Dye Dilution Technique (2017) (6)
- Use of antagonists of aldosterone in patients with chronic kidney disease: Potential advantages and risks. (2006) (5)
- A040: Omapatrilat increases plasma concentration of adrenomedullin in salt-sensitive hypertensives (2000) (5)
- Impotence in Uremia (1983) (5)
- Orthostatic hypotension: idiopathic and uremic. (1988) (5)
- Renal consequences of salt and hypertension. (1991) (5)
- Prognosis in acute renal failure accompanied by jaundice. (1981) (5)
- Effect of hypophosphatemia on brain catecholamines content in the rat. (1987) (5)
- Oxidative stress and sympathetic activity in hypertension. (2010) (4)
- Contrast-induced acute renal failure. (1987) (4)
- The relationship between body phosphate and blood pressure. (1984) (4)
- The Challenges of Blood Pressure Control in Dialysis Patients. (2015) (4)
- Abstract 2173: Effect of High-dose Atorvastatin on Changes in Renal Function: A Secondary Analysis of the Stroke Prevention by Aggressive Reduction of Cholesterol Levels (SPARCL) Trial (2007) (3)
- Effect of hypercalcemia on renal sympathetic nervous system activity. (1992) (3)
- Antihypertensive therapy and progression of renal failure. (1989) (3)
- Omapatrilat or lisinopril in salt-sensitive hypertensives (2000) (3)
- Renal Osteodystrophy and the Status of Aluminum and Other Trace Metals in CAPD Patients: A Panel * Review (1984) (2)
- Association Between APOL1 Genotype and Need for Kidney Replacement Therapy in Patients Without Diabetes: Does Age Matter? (2019) (2)
- Neurogenic factors in hypertension caused by renal injury (1997) (2)
- Antihypertensive drugs and the kidney (2004) (2)
- [Study of adrenergic receptors of the lower third of the human esophagus and cardia]. (1971) (2)
- Diuretics are preferred over angiotensin II-converting enzyme inhibitors for initial therapy of uncomplicated hypertension. (2007) (2)
- Functional Abnormalities of the Autonomic Nervous System in Uremic and Dialysis Patients (1982) (2)
- Drugs, Systemic Diseases, and the Kidney (2012) (2)
- Neurogenic factors in hypertension: therapeutic implications. (1994) (2)
- Resistant hypertension and obstructive sleep apnea in end-stage renal disease. (2012) (2)
- Comparing the efficacy of statins in various patient subgroups in the atorvastatin comparative cholesterol efficacy and safety study (ACCESS) (2000) (2)
- Evolving role of calcium antagonists in the management of hypertension. (2004) (2)
- Angiotensin-(1–7) and vasopeptidase inhibition (2000) (1)
- Management of Essential Hypertension (1987) (1)
- Plasma catecholamines and vascular reactivity in acute and chronic renal failure. (1985) (1)
- Renovascular disease: Is there still a role for revascularization? . (2018) (1)
- Predictors of blood pressure response to spironolactone. (2016) (1)
- CHAPTER 65 – Hypertension in Chronic Dialysis Patients (2008) (1)
- Effect of antihypertensive agents on renal function and on sodium-volume status. (1989) (1)
- Microalbuminuria in Patients with Essential Hypertension. Cardiovascular and Renal Implications (1998) (1)
- Identifying and treating hypertension in the black and Hispanic population. (1989) (1)
- The Effects of Bradykinin on Single Ranvier Node of Nerve Fibres in the Frog (1972) (1)
- EFFECT OF OMAPATRILAT AND LISINOPRIL ON PLASMA CONCENTRATIONS OF ADRENOMEDULLIN IN PATIENTS WITH SALT-SENSITIVE HYPERTENSION: P3.42 (2000) (1)
- THE TIME COURSE OF THERAPEUTIC INTERVENTIONS FOR COVID-19 (2020) (1)
- H8 Microalbuminuria (μA) in patients with hypertension (EH) predicts cardiovascular and renal events (1997) (1)
- Alpha1 adrenergic receptors in mesenteric arteries of rats with chronic renal failure (1988) (1)
- Microalbuminuria in Essential Hypertension. Significance for the Cardiovascular and Renal Systems (2000) (1)
- Reply to 'resistant hypertension and central aortic pressure'. (2014) (1)
- The role of endothelial factors, cyclosporine, and erythropoietin in hypertension in chronic renal failure (1992) (1)
- In memoriam: vincent louis dequattro, MD, FACP, FACC 1933–2001 (2002) (1)
- Neurogenic Factors in Hypertensive Patients with Chronic Renal Failure and on Dialysis (1996) (1)
- Prostacyclin modulates the vascular actions of calcium in humans. (1985) (1)
- THE EFFECTS OF VASOPEPTIDASE INHIBITION BY OMAPATRILAT IN SALT-SENSITIVE HYPERTENSIVES: P1.145 (2000) (0)
- A44 - Increased insulin response to an oral glucose load in salt-sensitive (SS) patients with hypertension (EH) (1995) (0)
- The Case for Dual Renin-Angiotensin System Inhibition—Reply (2009) (0)
- Measurement of Cardiac Output and Blood Volume During Hemodialysis with Fluorescent Dye Dilution Technique (2016) (0)
- Hypertension, SNS overactivity, and the kidney : adverse consequences and therapeutic outlook (2007) (0)
- OR-46: Angiotensin II (Ang II) stimulates sympathetic nerve (SNS) activity through activation of oxidative stress (2003) (0)
- Metabolic and Dietary Influences on Sympathetic Nervous System Activity (2011) (0)
- Renal Ischemia: How Commonly Does it Cause Renal Failure? (2006) (0)
- Reply to Mann (1993) (0)
- 18. Deranged renal hemodynamic adaptation to high sodium intake in salt-sensitive patients with essential hypertension: effect of nifedipine GITS (1991) (0)
- OR-14: Antagonists of aldosterone: A novel approach to reducing proteinuria in patients with chronic kidney disease? (2005) (0)
- [Pharmacological action of DMPP on the human cardia]. (1971) (0)
- Vincent Louis DeQuattro, MD, FACP, FACC: 1933–2001 (2001) (0)
- [Renal insufficiency in Asiatic cholera]. (1975) (0)
- HMG-CoA reductase inhibitors and the kidney. Commentary (2007) (0)
- 13. Effects of enalapril and nicardipine on urinary albumin excretion in patients with chronic renal insufficiency: a 1-year follow-up (1991) (0)
- Adrenergic nervous system in hypertension. (1985) (0)
- [Choleretic action of furosemide and of theophylline in the rat]. (1970) (0)
- [Physio-pharmacology of coronary insufficiency. I]. (1974) (0)
- Subject Index, Vol. 6 (Suppl. 1), 1986 (1986) (0)
- Consultant List (2002) (0)
- The Kidney in Hypertension (1983) (0)
- REFEREES (2007) (0)
- G029: Salt sensitivity and ethnic variations: Renin-angiotensin and natriuretic hormones (2000) (0)
- [Influence of bromazepam on the subacute toxicity and ECG changes caused by nicotine in guinea pigs]. (1974) (0)
- [Effects of dipyridamole on the isolated rat uterus]. (1974) (0)
- [Studies of the vasorelaxing mechanism of nicotine made by an analysis of the functional groups of the substance]. (1968) (0)
- Chapter 18 – Natriuretic Peptides (2005) (0)
- Opponent's comments. (2017) (0)
- [Ictero-uremigenic cholangitis]. (1972) (0)
- Acknowledgment to Reviewers (2020) (0)
- Acknowledgment of Reviewers (2006) (0)
- FUNCTION AND ON SODIUM-VOLUME STATUS (1989) (0)
- Acknowledgement to Reviewers (2012) (0)
- Recent Advances in the Role of the Renal Nervous System and Renin in Hypertension (1987) (0)
- Altering Serum Lipids to Reduce Progression of Chronic Kidney Disease (2013) (0)
- Association Between APOL1 Genotype and Risk of Kidney Replacement Therapy Requirement in Patients Without Diabetes: Does Age Matter? (2020) (0)
- [Action of morphine and strychnine on the stretch reflex of the guinea pig ileum]. (1967) (0)
- Alpha 1 adrenergic receptors in mesenteric arteries of rats with chronic renal failure. (1988) (0)
- [Renal complications of Asiatic cholera]. (1975) (0)
- Acknowledgment to Reviewers (1998) (0)
- P-513: Increased body mass index in patients with essential hypertension clusters with multiple cardiovascular risk factors (2005) (0)
- MICROALBUMINURIA IN ESSENTIAL HYPERTENSION: CARDIOVASCULAR AND RENAL IMPLICATIONS (2004) (0)
- [Effect of bradykinin on Ranvier's nodes of isolated nerve fibers in the frog]. (1971) (0)
- [Potentiation with cocaine of substances with tono-stimulating action on isolated arteries]. (1969) (0)
- renal disease sympathetic nerve activity in patients with end-stage Differential distribution of muscle and skin (2015) (0)
- 15th International Conference on Dialysis Advances in Chronic Kidney Disease 2013 (2013) (0)
- The kidney in hypertension. Introduction. (1983) (0)
- Activity Dependent Stimulation of Sympathetic Nerve − Oxidative Stress Mediates Angiotensin II (2005) (0)
- Quiz of the Month, Questions (1984) (0)
- [Physio-pharmacology of coronary insufficiency. II]. (1974) (0)
- Is deterioration of renal function in essential hypertension predictable? (1996) (0)
- [Importance of myogenic tonus for demonstration of the beta-receptors in isolated arterial preparation]. (1968) (0)
- acute injury-induced hypertension Responses of proximal tubule sodium transporters to (2016) (0)
- Diagnosis and evaluation of secondary hypertension. (1999) (0)
- Advances in Pathophysiology and Management of Hypertension (1989) (0)
- [Post-abortum acute renal insufficiency]. (1974) (0)
- Quiz of the month: question 1. (1983) (0)
- Sodium, Calcium, and Neurogenic Factors in the Pathogenesis of Essential Hypertension (1989) (0)
- Abstracts of papers presented at the meeting but not submitted to the supplement. 1. Intracellular calcium in lymphocytes of salt-sensitive patients with essential hypertension: effect of dietary sodium intake and nifedipine (1991) (0)
- Quiz of month: question 2. (1983) (0)
- Calcium, Phosphate, and Parathyroid Hormone in Blood Pressure Regulation (1984) (0)
- [Medical treatment of malignant hypertension. Physiopathological basis and results of treatment with sympatholytic drugs, heparin and dipyridamole]. (1974) (0)
- [Proposal for a modification of Jirgl's test for better differentiation of jaundices]. (1968) (0)
- [Choleretic action of ethacrynic acid in the rat]. (1971) (0)
- Selected Abstracts from the 31th International Vicenza Course on Critical Care Nephrology. Vicenza, June 11-14, 2013 (2013) (0)
- [Influence of bromazepam and of diazepam on the acute toxicity and ECG changes caused by nicotine in guinea pigs]. (1974) (0)
- ACE Inhibitors: Over Two Decades of Use (2005) (0)
- Interleukin-1 b and neurogenic control of blood pressure in normal rats and rats with chronic renal failure (2000) (0)
- Management of essential hypertension. Whom, when and how to treat. (1987) (0)
- Neurogenic Factors in Hypertension Associated With Chronic Kidney Disease (2015) (0)
- Pressors for Intradialytic Hypotension (1989) (0)
- Subdiaphragmatic fluid mimicking loculated pericardial effusion on echocardiography. (1984) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Vito M. Campese?
Vito M. Campese is affiliated with the following schools:
